Drug Trial Radar · NCT05586971
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Last checked: Nov 20, 2026Latest source record: Jul 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,202
Actual
Start
Mar 30, 2023
Primary completion
May 6, 2025
Study completion May 6, 2025
Sponsor
- Lead sponsor
- LG ChemIndustry
- Sponsor type
- Industry
- First posted
- Oct 19, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this 12-month randomized multi-regional double-blind parallel group allopurinol and placebo-controlled phase 3 study is to assess the efficacy and safety of three different doses of Tigulixostat in gout patients with hyperuricemia.
Conditions
- Gout
- Hyperuricemia
- Gout Flare
- Tophi
Interventions
TigulixostatDrug
Xanthine Oxidase Inhibitor
AllopurinolDrug
Xanthine Oxidase Inhibitor
PlaceboDrug
Matching placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- The proportion of subjects with sUA levels <6.0 mg/dL sustained at months 4, 5, and 6Time frame: Up to Month 6
Locations
279 sites in 21 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Alliance for Multispecialty Research, LLC
Daphne, Alabama
Alliance for Multispecialty Research, LLC
Mobile, Alabama
Syed Research Consultants, LLC
Muscle Shoals, Alabama
Syed Research Consultants, LLC
Sheffield, Alabama
Arizona Research Clinic, PLLC
Chandler, Arizona
Arizona Arthritis & Rheumatology Associates, P.C.
Flagstaff, Arizona
Arizona Arthritis and Rheumatology Research PLLC
Glendale, Arizona
Arizon Arthritis & Rheumatology Research, PLLC
Mesa, Arizona
Desert Clinical Research/CCT Research
Mesa, Arizona
Elite Clinical Studies, LLC
Phoenix, Arizona
Fiel Family and Sports Medicine/CCT Research
Tempe, Arizona
Lynn Institute of the Ozarks
Little Rock, Arkansas
Velocity Clinical Research
Banning, California
American Clinical Trials
Buena Park, California
Shreenath Clinical Service
Lakewood, California
Rancho Cucamonga Clinical Research
Rancho Cucamonga, California
TriWest Research Associates
San Diego, California
Rheumatology Center of San Diego
San Diego, California
Arthritis & Rheumatic Disease Specialties
Aventura, Florida
Clinical Research of West Florida, Inc.
Clearwater, Florida
Herco Medical and Research Center, Inc
Coral Gables, Florida
Nouvelle Clinical Research LLC
Cutler Bay, Florida
Omega Research Debary, LLC
DeBary, Florida
Alliance for Multispecialty Research, LLC
Fort Myers, Florida
Direct Helpers Research Center
Hialeah, Florida
Best Quality Research, Inc
Hialeah, Florida
New Generation Of Medical Research, LLC
Hialeah, Florida
Vital Pharma Research
Hialeah, Florida
Accel Research Sites - Lakeland
Lake Mary, Florida
Accel Research Sites - St. Petersburg- Largo
Lake Mary, Florida
ARS-Matiland Clinical Research Unit
Lake Mary, Florida
Homestead Associates in Research,Inc
Miami, Florida
Allied Biomedical Research Institute
Miami, Florida
D&H National Research Centers, Inc.
Miami, Florida
Ivetmar Medical Group, LLC
Miami, Florida
Care Research Center Inc
Miami, Florida
Pharmax Research of South Florida, Inc
Miami, Florida
Miami Dade Medical Research Institute, LLC
Miami, Florida
Clinical Site Partners, LLC dba Flourish Research
Miami, Florida
Showing 40 of 279 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.